Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAR 23 ... Drugs, Oncology, Pharmaceuticals, Therapies, Therapy, Treatment, Tumor Suppression, Introgen Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2009 FEB 16 ... dysfunctional p53 are predisposed to the development of cancer phenotype. Advexin (R) (Introgen Therapeutics Inc., TX, USA) is an adenoviral-based experimental therapeutic that provides delivery of ...
2008 AUG 11 ... Molecular Therapies, Oncology, Pharmaceuticals, Therapy, Treatment, Tumor Suppression, Introgen Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 JUN 23 ... Agreements, Pharmaceuticals, Public Health, Therapies, Therapy, Treatment, Vaccines, Introgen Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 JUN 9 ... Head and Neck Cancer, Head and Neck Neoplasms, Oncology, Treatment, Tumor Suppression, Introgen Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 AUG 18 ... Research, Molecular Therapies, Oncology, Pharmaceuticals, Regulatory Actions, Treatment, Introgen Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 AUG 4 ... Neck Neoplasms, Molecular Research, Molecular Therapies, Oncology, Therapy, Treatment, Introgen Therapeutics Inc.
This article was prepared by Biotech Business Week editors from staff ...
2008 SEP 8 ... spans more than two decades. He was most recently VP, Research and Development with Introgen Research Institute and Associate VP, Clinical Research and Development for Introgen ... control systems to enhance the safety and efficacy of existing and novel biological therapeutics, announced the appointment of Sunil Chada, Ph.D as the Senior Vice President of Clinical ...
2008 SEP 1 ... he assumed increasingly more important positions working at Genetic Therapy Inc., IntrogenTherapeutics, Inc., and Targeted Genetics Corp. on process development and GMP ...
